−52.1
Aclaris Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−67.6
FY23:
−78.3
FY24:
−20.1
FY25:
−47.1
Change from FY21 to FY25
millions USD
FY21:
−168
FY22:
12.6
FY23:
46.2
FY24:
−69.8
FY25:
48.4
Change from FY21 to FY25
millions USD
FY21:
225
FY22:
72.9
FY23:
26.7
FY24:
74.5
FY25:
−5.86
millions USD
FY21:
5.29
FY22:
17.9
FY23:
−5.40
FY24:
−15.3
FY25:
−4.61
(positive)
Change from FY21 to FY25
millions USD
FY21:
−52.4
FY22:
−68.2
FY23:
−79.6
FY24:
−20.2
FY25:
−47.2
All amounts in millions USD